Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Yakult Honsha: Pharma Sales Up 31% Driven by Elplat
November 26, 2007
- R&D NEWS IN BRIEF
November 26, 2007
- Seikagaku Corp.: Artz Drives Sales 12.9%
November 26, 2007
- REGULATORY NEWS IN BRIEF
November 26, 2007
- Nissan Chemical:Pharma Sales Down to \3,415 Mil.
November 26, 2007
- MEDICAL DEVICE NEWS IN BRIEF
November 26, 2007
- Top-4 Wholesalers Keep Operating Profit Rates Above 1%
November 26, 2007
- There Is No Legal Ground for Ban on Kongo Shinryo: Court Ruling
November 26, 2007
- Mediceo Paltac to Expand Its Share on Market for Dispensing Pharmacies
November 26, 2007
- NEW PRODUCTS／POLA Pharma Launches Estradiol Gel
November 26, 2007
- Alfresa: Good Sales to Dispensing Pharmacies Drive Business
November 26, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 26, 2007
- Suzuken: Two-Digit Growth in Sales, Profits
November 26, 2007
- Ono to Minimize Impact of Generics by Further Expanding the Market
November 26, 2007
- Aiming at Launching at Least One Product per Year: Genzyme
November 26, 2007
- Toho Pharm.: Operating Profits Down 1.1% Due to Cost of Distribution Center
November 26, 2007
- TOPICS／Eli Lilly Japan Introduces Mentor System for Female MRs
November 26, 2007
- AnGes MG Licenses NF-kB Decoy Oligo to Meyer Pharm.
November 26, 2007
- Santen: Good Sales in Europe Drive Business
November 26, 2007
- BUSINESS NEWS IN BRIEF
November 26, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…